Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2003-7-8
pubmed:abstractText
The cytokine/extracellular matrix protein osteopontin (OPN/Eta-1) is an important component of cellular immunity and inflammation. It also acts as a survival, cell-adhesive, and chemotactic factor for endothelial cells. Here, subtractive suppression hybridization showed that serum-deprived murine aortic endothelial (MAE) cells transfected with the angiogenic fibroblast growth factor-2 (FGF2) overexpress OPN compared with parental cells. This was confirmed by Northern blotting and Western blot analysis of the conditioned media in different clones of endothelial cells overexpressing FGF2 and in endothelial cells treated with the recombinant growth factor. In vivo, FGF2 caused OPN expression in newly formed endothelium of the chick embryo chorioallantoic membrane (CAM) and of murine s.c. Matrigel plug implants. Recombinant OPN (rOPN), the fusion protein GST-OPN, and the deletion mutant GST-DeltaRGD-OPN were angiogenic in the CAM assay. Angiogenesis was also triggered by OPN-transfected MAE cells grafted onto the CAM. OPN-driven neovascularization was independent from endothelial alpha(v)beta(3) integrin engagement and was always paralleled by the appearance of a massive mononuclear cell infiltrate. Accordingly, rOPN, GST-OPN, GST-DeltaRGD-OPN, and the conditioned medium of OPN-overexpressing MAE cells were chemotactic for isolated human monocytes. Also, rOPN triggered a proangiogenic phenotype in human monocytes by inducing the expression of the angiogenic cytokines TNF-alpha and IL-8. OPN-mediated recruitment of proangiogenic monocytes may represent a mechanism of amplification of FGF2-induced neovascularization during inflammation, wound healing, and tumor growth.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
171
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1085-93
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12847283-Angiogenesis Inducing Agents, pubmed-meshheading:12847283-Animals, pubmed-meshheading:12847283-Cell Line, pubmed-meshheading:12847283-Cell Line, Transformed, pubmed-meshheading:12847283-Cell Movement, pubmed-meshheading:12847283-Chick Embryo, pubmed-meshheading:12847283-Chorion, pubmed-meshheading:12847283-Endothelium, Vascular, pubmed-meshheading:12847283-Fibroblast Growth Factor 2, pubmed-meshheading:12847283-Humans, pubmed-meshheading:12847283-Immunophenotyping, pubmed-meshheading:12847283-Integrin alphaVbeta3, pubmed-meshheading:12847283-Interleukin-6, pubmed-meshheading:12847283-Interleukin-8, pubmed-meshheading:12847283-Mice, pubmed-meshheading:12847283-Mice, Inbred BALB C, pubmed-meshheading:12847283-Monocytes, pubmed-meshheading:12847283-Neovascularization, Physiologic, pubmed-meshheading:12847283-Osteopontin, pubmed-meshheading:12847283-Recombinant Proteins, pubmed-meshheading:12847283-Sialoglycoproteins, pubmed-meshheading:12847283-Tumor Necrosis Factor-alpha, pubmed-meshheading:12847283-Up-Regulation
pubmed:year
2003
pubmed:articleTitle
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis.
pubmed:affiliation
Unit of General Pathology and Immunology, Department of Biomedical Sciences and Biotechnology, University of Brescia, Brescia, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't